LLY insider ownership: who sold, why, and what they still hold

Who	Shares	Price	% of total stake	Total stake after	Trade date	Filed
Melissa Seymour EVP, Global Quality	12	n/a	n/a	n/a	Sep 9, 2026	Sep 11, 2026

What stands out

Outside holder LILLY ENDOWMENT INC, a 10% owner and not part of management, sold $2.58B of stock. A further 73K shares are left out of that figure: the price as filed looks like a typo.Largest sale, Oct 31, 2025

Donald Zakrowski sold 54% of vested holdings: 3K shares for $3.4M, all under a disclosed plan.Largest sale, Aug 10, 2026

Selling picked up in the last 90 days: officers and directors sold 14K shares, against an average of 1.1K per 90 days earlier in the period. Most of it was Patrik Jonsson (6.5K shares in the last 90 days, 12% of holdings) and Anat Hakim (5K shares in the last 90 days, 11% of holdings); 100% of these sales were under disclosed plans.Patrik Jonsson: largest recent sale, Aug 17, 2026 · Anat Hakim: largest recent sale, Aug 7, 2026

Percentages cover 22 of 26 officers and directors. 4 are left out

Left out: Jacob Van Naarden, Eric Dozier and Melissa Seymour (holdings couldn't be fully reconciled); Carole Ho (held no vested shares at the start).

Disclosed company stock is not an insider's whole wealth.

Who sold, and how much of their stake

Officers and directors, past 12 months. Each bar is the insider's vested stake at the start of the period (Oct 8, 2025). The gold part is what they sold.

SoldRest of starting stakeAdded during the period

Patrik Jonsson

EVP & President, LLY Int'l

Sold 12%, but 3.9K shares were added (mostly vesting), so the stake grew

12% · $7.6MDisclosed plan

Anat Hakim

EVP, GC & Secretary

Sold 11%, but 6.7K shares were added (mostly vesting), so the stake grew

11% · $6.0MDisclosed plan

Donald Zakrowski

SVP, Finance, & CAO

54% · $3.4MDisclosed plan

Ilya Yuffa

EVP&Pres, LLY USA&Global Capab

Sold 9.5%, but 3.4K shares were added (mostly vesting), so the stake grew

9.5% · $2.9MDisclosed plan

Amounts, filings and trading plans for each seller

Selling by month

Officers and directors, Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planTo cover taxesNo plan disclosed

Outside holders, reported separately

LILLY ENDOWMENT INC sold $2.58B in the past 12 months. Large shareholders and the funds or companies that board members represent are not part of management, so they are left out of the figures above.

Details

Common questions

Is the Eli Lilly CEO selling stock?

No. David Ricks reported no open-market sales in the past 12 months.

Why are Eli Lilly insiders selling?

Filings rarely give a reason, and we don't guess at one. What they show is how the sales were made: 100% of sales by value ran under 10b5-1 trading plans disclosed in the filings. A trading plan schedules sales in advance.

Are any Eli Lilly insiders buying?

No. Officers and directors reported no purchases in the past 12 months.

How much of their stake did Eli Lilly insiders sell?

About 1.3% overall. As a group they ended with more shares than they started with. The biggest individual seller, Patrik Jonsson, sold shares equal to 12% of starting holdings, but more vested, so the stake grew. That covers the 12 months to Oct 8, 2026 and counts vested shares reported on SEC Forms 3, 4 and 5, which is not an insider's whole wealth.

The evidence

Who sold4 officers and directors: amount, % of holdings, trading plan

Who sold	Amount	% of holdings	Trading plan
Patrik Jonsson EVP & President, LLY Int'l	$7.6M 6.5K shares	12%	Disclosed plan
Anat Hakim EVP, GC & Secretary	$6.0M 5K shares	11%	Disclosed plan
Donald Zakrowski SVP, Finance, & CAO	$3.4M 3K shares	54%	Disclosed plan
Ilya Yuffa EVP&Pres, LLY USA&Global Capab	$2.9M 2.5K shares	9.5%	Disclosed plan

Outside holder, reported separately: LILLY ENDOWMENT INC (a 10% owner, not part of management). Sold $2.58B (2.67M shares) from Oct 9, 2025 to May 6, 2026. Holds 91.88M shares. Latest filing

The full ownership picture23 of 26 insiders fully reconciled · 25 officers and directors

Vested shares across all share classes, held directly and through trusts, LLCs and family members, as reported on SEC Forms 3, 4 and 5. Unvested awards and options are never counted as owned shares.

Insider

Held Oct 8, 2025

Sold

Held Oct 8, 2026

Still held

David Ricks

Minor difference of 12 shares. Difference is under 0.5% of holdings.

President, Chair, and CEO, Director

677K

709K

no sales

Vesting, gifts, unvested awards and holding lines for David Ricks

+32Kshares vested or exercised

−25Kgifted (net of own trusts)

−14Kwithheld by the company for taxes

32K → 0unvested awards, start → end

Held through	Share class	Oct 8, 2025	Oct 8, 2026
Direct	Common Stock	546,601	571,715
David A. Ricks SLAT	Common Stock	68,656	68,656
David A. Ricks 2022 GRAT	Common Stock	54,117	54,117
401(k)	Common Stock	7,296	7,308
Trust	Common Stock	300	300
David A. Ricks 2025 GRAT	Common Stock	0	6,685

Reconciliation: minor difference of 12 shares. Difference is under 0.5% of holdings.

Daniel Skovronsky

EVP, CS&PO & Pres. LRL

213K

236K

no sales

Vesting, gifts, unvested awards and holding lines for Daniel Skovronsky

+13Kshares vested or exercised

−179gifted (net of own trusts)

−5.6Kwithheld by the company for taxes

13K → 0unvested awards, start → end

Held through	Share class	Oct 8, 2025	Oct 8, 2026
Direct	Common Stock	137,660	160,072
Trust	Common Stock	72,359	72,359
spouse's SLAT	Common Stock	2,510	2,710
Spouse	Common Stock	747	547

Erik Fyrwald

Minor difference of 454 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Director

75K

76K

no sales

Vesting, gifts, unvested awards and holding lines for Erik Fyrwald

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Held through	Share class	Oct 8, 2025	Oct 8, 2026
Direct	Common Stock	74,751	75,536

Reconciliation: minor difference of 454 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Ralph Alvarez

Minor difference of 342 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Director

56K

57K

no sales

Vesting, gifts, unvested awards and holding lines for Ralph Alvarez

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Held through	Share class	Oct 8, 2025	Oct 8, 2026
Direct	Common Stock	55,138	55,838
Trust	Common Stock	758	758

Reconciliation: minor difference of 342 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Patrik Jonsson

Minor difference of 58 shares. Difference is under 0.5% of holdings.

EVP & President, LLY Int'l

54K

−6.5K

55K

+1%

Vesting, gifts, unvested awards and holding lines for Patrik Jonsson

+3.9Kshares vested or exercised

0gifted (net of own trusts)

−1.8Kwithheld by the company for taxes

3.9K → 0unvested awards, start → end

Held through	Share class	Oct 8, 2025	Oct 8, 2026
Direct	Common Stock	53,651	54,147
401(k)	Common Stock	575	632

Reconciliation: minor difference of 58 shares. Difference is under 0.5% of holdings.

Anat Hakim

EVP, GC & Secretary

44K

−5K

51K

+16%

Vesting, gifts, unvested awards and holding lines for Anat Hakim

+6.7Kshares vested or exercised

0gifted (net of own trusts)

−3Kwithheld by the company for taxes

6.7K → 0unvested awards, start → end

Held through	Share class	Oct 8, 2025	Oct 8, 2026
Direct	Common Stock	10,963	22,987
Spouse	Common Stock	16,875	11,875
Anat Hakim SLAT	Common Stock	15,700	15,700

Edgardo Hernandez

Minor difference of 2 shares. Difference is under 0.5% of holdings.

EVP & Pres., Mfg. Operations

41K

47K

no sales

Vesting, gifts, unvested awards and holding lines for Edgardo Hernandez

+3.6Kshares vested or exercised

−13gifted (net of own trusts)

−1.6Kwithheld by the company for taxes

3.6K → 0unvested awards, start → end

Held through	Share class	Oct 8, 2025	Oct 8, 2026
Direct	Common Stock	39,731	46,083
401(k)	Common Stock	872	874

Reconciliation: minor difference of 2 shares. Difference is under 0.5% of holdings.

Jacob Van Naarden

Holdings couldn't be fully reconciled. Balance changed with no matching transaction and no footnote: -1,000 shares on Feb 9, 2026 (Direct). See the filing Sales and other transactions for Jacob Van Naarden are complete.

EVP,Pres LLY Oncology&HdCorpBD

n/a

Vesting, gifts, unvested awards and holding lines for Jacob Van Naarden

+4.1Kshares vested or exercised

0gifted (net of own trusts)

−1.9Kwithheld by the company for taxes

4.1K → 0unvested awards, start → end

Holdings couldn't be fully reconciled. Balance changed with no matching transaction and no footnote: -1,000 shares on Feb 9, 2026 (Direct). The balances below are as reported, not verified totals.

Held through	Share class	Oct 8, 2025	Oct 8, 2026
Direct	Common Stock	20,562	26,626
Van Naarden Family Trust	Common Stock	4,342	4,342
Spouse	Common Stock	4,302	4,302
SLAT	Common Stock	0	5,302

Ilya Yuffa

EVP&Pres, LLY USA&Global Capab

26K

−2.5K

30K

+14%

Vesting, gifts, unvested awards and holding lines for Ilya Yuffa

+3.4Kshares vested or exercised

0gifted (net of own trusts)

−1.5Kwithheld by the company for taxes

3.4K → 0unvested awards, start → end

Held through	Share class	Oct 8, 2025	Oct 8, 2026
Direct	Common Stock	26,260	29,804

Katherine Baicker

Minor difference of 169 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Director

23K

24K

no sales

Vesting, gifts, unvested awards and holding lines for Katherine Baicker

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Held through	Share class	Oct 8, 2025	Oct 8, 2026
Direct	Common Stock	23,118	23,503

Reconciliation: minor difference of 169 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

William Kaelin Jr.

Minor difference of 157 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Director

21K

22K

no sales

Vesting, gifts, unvested awards and holding lines for William Kaelin Jr.

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Held through	Share class	Oct 8, 2025	Oct 8, 2026
Direct	Common Stock	21,465	21,837

Reconciliation: minor difference of 157 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Diogo Rau

EVP & Cido

20K

26K

no sales

Vesting, gifts, unvested awards and holding lines for Diogo Rau

+3.8Kshares vested or exercised

0gifted (net of own trusts)

−1.7Kwithheld by the company for taxes

3.8K → 0unvested awards, start → end

Held through	Share class	Oct 8, 2025	Oct 8, 2026
Direct	Common Stock	19,719	26,397

Juan Luciano

Minor difference of 104 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Director

16K

17K

no sales

Vesting, gifts, unvested awards and holding lines for Juan Luciano

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Held through	Share class	Oct 8, 2025	Oct 8, 2026
Direct	Common Stock	16,456	16,957

Reconciliation: minor difference of 104 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Lucas Montarce

EVP & CFO

15K

16K

no sales

Vesting, gifts, unvested awards and holding lines for Lucas Montarce

+368shares vested or exercised

0gifted (net of own trusts)

−160withheld by the company for taxes

2.3K → 2Kunvested awards, start → end

Held through	Share class	Oct 8, 2025	Oct 8, 2026
Direct	Common Stock	14,685	16,258

Eric Dozier

Holdings couldn't be fully reconciled. Balance changed with no matching transaction and no footnote: +42.34 shares on Feb 1, 2026 (401(k)). See the filing Sales and other transactions for Eric Dozier are complete.

EVP, Chief People Officer

n/a

Vesting, gifts, unvested awards and holding lines for Eric Dozier

+2.9Kshares vested or exercised

−697gifted (net of own trusts)

−1.3Kwithheld by the company for taxes

2.9K → 0unvested awards, start → end

Holdings couldn't be fully reconciled. Balance changed with no matching transaction and no footnote: +42.34 shares on Feb 1, 2026 (401(k)). The balances below are as reported, not verified totals.

Held through	Share class	Oct 8, 2025	Oct 8, 2026
Direct	Common Stock	9,839	14,239
401(k)	Common Stock	335	413

Jamere Jackson

Minor difference of 18 shares. Difference is under 0.5% of holdings.

Director

9.4K

9.6K

no sales

Vesting, gifts, unvested awards and holding lines for Jamere Jackson

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Held through	Share class	Oct 8, 2025	Oct 8, 2026
Direct	Common Stock	9,402	9,635

Reconciliation: minor difference of 18 shares. Difference is under 0.5% of holdings.

Kenneth Custer

Minor difference of 19 shares. Difference is under 0.5% of holdings.

EVP & President, Card Met Hlth

9.3K

10K

no sales

Vesting, gifts, unvested awards and holding lines for Kenneth Custer

+207shares vested or exercised

0gifted (net of own trusts)

−91withheld by the company for taxes

7.5K → 7.3Kunvested awards, start → end

Held through	Share class	Oct 8, 2025	Oct 8, 2026
Direct	Common Stock	9,347	10,141

Reconciliation: minor difference of 19 shares. Difference is under 0.5% of holdings.

Donald Zakrowski

Minor difference of 9 shares. Difference is under 0.5% of holdings.

SVP, Finance, & CAO

5.6K

−3K

3.3K

59%

Vesting, gifts, unvested awards and holding lines for Donald Zakrowski

+184shares vested or exercised

0gifted (net of own trusts)

−82withheld by the company for taxes

586 → 602unvested awards, start → end

Held through	Share class	Oct 8, 2025	Oct 8, 2026
Direct	Common Stock	3,840	1,526
401(k)	Common Stock	1,726	1,735

Reconciliation: minor difference of 9 shares. Difference is under 0.5% of holdings.

Adrienne Brown

Started reporting during the period; starting holdings are from the Form 3.

EVP, President LLY Imm

3.7K

5.1K

no sales

Vesting, gifts, unvested awards and holding lines for Adrienne Brown

+391shares vested or exercised

0gifted (net of own trusts)

−170withheld by the company for taxes

3.7K → 3.3Kunvested awards, start → end

Started reporting during the period; starting holdings are from the Form 3.

Held through	Share class	Oct 8, 2025	Oct 8, 2026
Direct	Common Stock	3,725	5,142

Kimberly Johnson

Minor difference of 17 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Director

3.3K

no sales

Vesting, gifts, unvested awards and holding lines for Kimberly Johnson

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Held through	Share class	Oct 8, 2025	Oct 8, 2026
Direct	Common Stock	3,032	3,265

Reconciliation: minor difference of 17 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Gabrielle Sulzberger

Director

2.7K

no sales

Vesting, gifts, unvested awards and holding lines for Gabrielle Sulzberger

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Held through	Share class	Oct 8, 2025	Oct 8, 2026
Direct	Common Stock	2,722	3,012

Reconciliation: minor difference of 17 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Mary Hedley

Minor difference of 3 shares. Difference is under 0.5% of holdings.

Director

2.1K

2.4K

no sales

Vesting, gifts, unvested awards and holding lines for Mary Hedley

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Held through	Share class	Oct 8, 2025	Oct 8, 2026
Direct	Common Stock	2,003	2,253
Trust	Common Stock	98	98

Reconciliation: minor difference of 3 shares. Difference is under 0.5% of holdings.

Carolyn Bertozzi

Started reporting during the period; starting holdings are from the Form 3. New Form 3 filed 2025-12-08; earlier filings set aside.

Director

no sales

Vesting, gifts, unvested awards and holding lines for Carolyn Bertozzi

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Started reporting during the period; starting holdings are from the Form 3.
New Form 3 filed 2025-12-08; earlier filings set aside.

Held through	Share class	Oct 8, 2025	Oct 8, 2026
Direct	Common Stock	2,000	2,000

Melissa Seymour

Holdings couldn't be fully reconciled. Balance changed with no matching transaction and no footnote: -525.293 shares on Aug 1, 2026 (Direct). See the filing Sales and other transactions for Melissa Seymour are complete.

EVP, Global Quality

n/a

Vesting, gifts, unvested awards and holding lines for Melissa Seymour

+981shares vested or exercised

−12gifted (net of own trusts)

−439withheld by the company for taxes

1.9K → 952unvested awards, start → end

Holdings couldn't be fully reconciled. Balance changed with no matching transaction and no footnote: -525.293 shares on Aug 1, 2026 (Direct). The balances below are as reported, not verified totals.

Held through	Share class	Oct 8, 2025	Oct 8, 2026
Direct	Common Stock	1,050	1,038

Jon Moeller

Director

304

no sales

Vesting, gifts, unvested awards and holding lines for Jon Moeller

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Held through	Share class	Oct 8, 2025	Oct 8, 2026
Direct	Common Stock	71	304

23 of 26 insiders fully reconciled: starting holdings plus reported transactions match ending holdings (9 exactly, 14 with a minor or footnoted difference). For 3 we show sales but not holdings; the ! icon on their rows explains why. Percentages cover 22 of 26 officers and directors. Left out: Jacob Van Naarden, Eric Dozier and Melissa Seymour (holdings couldn't be fully reconciled); Carole Ho (held no vested shares at the start). "Still held" compares ending with starting vested shares; a plus sign means the holding grew.

What explains the selling$19.8M of sales by plan status, purpose, seller and month

Officer and director open-market sales: $19.8M across 17,000 shares. Plan status and stated purpose are separate questions, and a sale can have both.

By plan status

Disclosed plan · $19.8M · 100%

Taxes

33,544 shares ($34.8M) were withheld by the company for taxes, which isn't a market sale.

Seller	Shares sold	Proceeds	Under a disclosed plan	Share of total	Sales dates
Patrik Jonsson EVP & President, LLY Int'l	6.5K	$7.6M	100%	38%	Aug 17, 2026 to Aug 17, 2026
Anat Hakim EVP, GC & Secretary	5K	$6.0M	100%	30%	Aug 7, 2026 to Aug 7, 2026
Donald Zakrowski SVP, Finance, & CAO	3K	$3.4M	100%	17%	Nov 13, 2025 to Aug 10, 2026
Ilya Yuffa EVP&Pres, LLY USA&Global Capab	2.5K	$2.9M	100%	14%	Jun 10, 2026 to Jun 10, 2026

Sales by month

Month	Sale proceeds	Disclosed plan	To cover taxes	No plan disclosed
Oct 2025	$0	$0	$0	$0
Nov 2025	$1.0M	$1.0M	$0	$0
Dec 2025	$0	$0	$0	$0
Jan 2026	$0	$0	$0	$0
Feb 2026	$0	$0	$0	$0
Mar 2026	$0	$0	$0	$0
Apr 2026	$0	$0	$0	$0
May 2026	$0	$0	$0	$0
Jun 2026	$2.9M	$2.9M	$0	$0
Jul 2026	$0	$0	$0	$0
Aug 2026	$16.0M	$16.0M	$0	$0
Sep 2026	$0	$0	$0	$0
Oct 2026	$0	$0	$0	$0

Is this normal? Selling year by year5 earlier years to compare with

More than usual: about 1.7x the 5-year average. 4 insiders sold; the average is 3 a year.

12 months ending	Shares sold	Insiders who sold	Proceeds
Oct 8, 2026 Latest 12 months	17K	4	$19.8M
Oct 8, 2025 1 year earlier	11K	3	$9.0M
Oct 8, 2024 2 years earlier	10K	2	$8.1M
Oct 9, 2023 3 years earlier	19K	5	$7.8M
Oct 9, 2022 4 years earlier	7.7K	4	$2.1M
Oct 9, 2021 5 years earlier	3K	1	$544K

Open-market sales (Form 4 code S) by people who were officers or directors, in split-adjusted shares. Earlier years include people who have since left. A sale that an outside holder also reports (a family trust, a fund) is counted with outside holders in every year. Shares, not dollars, are compared, so a change in the stock price doesn't look like a change in selling. Years the filings don't fully cover are shown but left out of the average.

Known gaps and uncertainty3 insiders whose holdings couldn't be fully reconciled

Jacob Van Naarden: holdings couldn't be fully reconciled (difference of 4,302 shares). Balance changed with no matching transaction and no footnote: -1,000 shares on Feb 9, 2026 (Direct). Filing, Feb 9, 2026

Eric Dozier: holdings couldn't be fully reconciled (difference of 79 shares). Balance changed with no matching transaction and no footnote: +42.34 shares on Feb 1, 2026 (401(k)). Filing, Feb 1, 2026

Melissa Seymour: holdings couldn't be fully reconciled (difference of -542 shares). Balance changed with no matching transaction and no footnote: -525.293 shares on Aug 1, 2026 (Direct). Filing, Aug 1, 2026

David Ricks: minor difference of 12 shares. Difference is under 0.5% of holdings.

Erik Fyrwald: minor difference of 454 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Ralph Alvarez: minor difference of 342 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Patrik Jonsson: minor difference of 58 shares. Difference is under 0.5% of holdings.

Edgardo Hernandez: minor difference of 2 shares. Difference is under 0.5% of holdings.

Katherine Baicker: minor difference of 169 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

William Kaelin Jr.: minor difference of 157 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Juan Luciano: minor difference of 104 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Jamere Jackson: minor difference of 18 shares. Difference is under 0.5% of holdings.

Kenneth Custer: minor difference of 19 shares. Difference is under 0.5% of holdings.

Donald Zakrowski: minor difference of 9 shares. Difference is under 0.5% of holdings.

Kimberly Johnson: minor difference of 17 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Gabrielle Sulzberger: minor difference of 17 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Mary Hedley: minor difference of 3 shares. Difference is under 0.5% of holdings.

Inferred rename: "wife, K. Taurel" is treated as the same holder as "Sidney Taurel 2008-2 GRAT", because the old name was never reported again and the new one opened with the same balance (100,000 shares). Old name, new name

Inferred rename: "Sidney Taurel 2008-2 GRAT" is treated as the same holder as "Sidney Taurel 2008-AT GRAT", because the old name was never reported again and the new one opened with the same balance (100,000 shares). Old name, new name

Inferred rename: "Sidney Taurel 2008-AT GRAT" is treated as the same holder as "Sidney Taurel Family Investment GRAT IV", because the old name was never reported again and the new one opened with the same balance (100,000 shares). Old name, new name

External context: we only cite outside events when a documented connection exists. None is shown for this period.

Sources and methodology2,757 filings from SEC EDGAR, and how we read them

All 2,757 Forms 3, 4 and 5 filed for Eli Lilly (SEC CIK 59478) from May 30, 2003 to Sep 22, 2026, retrieved from SEC EDGAR on Oct 8, 2026. Prices are the ones reported in each filing, often weighted averages. 52 filings were left out because Eli Lilly filed them as an owner of another company's stock.

Holdings. Each holding line (a share class plus an owner, such as a trust or LLC) carries its last reported balance forward. Entities first reported during the period start at zero, so transfers between an insider's own trusts don't count as selling. Lines not reported for three years or more are listed separately and left out of totals.

Sales. A sale counts as under a 10b5-1 plan if its footnote cites one or the filing's Rule 10b5-1 box is checked, and as tax-related if its footnote cites tax obligations or sell-to-cover. Shares withheld by the company for taxes are listed separately. Sales with neither attribute are labeled "no plan disclosed".

Full methodology

Former or inactive filers (60)No filing in 18 months; last reported balances, not in any total

Name	Last filed	Last reported balance
Anne White	Feb 12, 2025	74,210 shares, last reported balance as of Feb 10, 2025
Karen Walker	Nov 20, 2024	6,249 shares, last reported balance as of Nov 18, 2024
Gordon Brooks	Jul 19, 2024	16,097 shares, last reported balance as of Jul 15, 2024
Johna Norton	Jun 3, 2024	27,728 shares, last reported balance as of Jun 3, 2024
Anat Ashkenazi	Feb 14, 2024	42,520 shares, last reported balance as of Feb 12, 2024
Alonzo Weems	Feb 14, 2024	7,951 shares, last reported balance as of Feb 12, 2024
Marschall Runge	Nov 21, 2023	16,593 shares, last reported balance as of Nov 20, 2023
Jackson Tai	Apr 19, 2023	63,789 shares, last reported balance as of Apr 17, 2023
Leigh Pusey	Feb 14, 2023	31,641 shares, last reported balance as of Feb 10, 2023
Michael Mason	Feb 14, 2023	40,241 shares, last reported balance as of Feb 10, 2023
Stephen Fry	Feb 11, 2022	152,812 shares, last reported balance as of Feb 9, 2022
Michael Eskew	Nov 17, 2021	45,080 shares, last reported balance as of Nov 15, 2021
Melissa Barnes	Feb 10, 2021	35,543 shares, last reported balance as of Feb 8, 2021
Alfonso Zulueta	Feb 10, 2021	61,614 shares, last reported balance as of Feb 8, 2021
Aarti Shah	Feb 10, 2021	34,595 shares, last reported balance as of Feb 8, 2021
Myles O'Neill	Feb 10, 2021	82,923 shares, last reported balance as of Feb 8, 2021
Joshua Smiley	Feb 10, 2021	79,810 shares, last reported balance as of Feb 8, 2021
Kathi Seifert	Nov 18, 2020	77,038 shares, last reported balance as of Nov 16, 2020
Michael Harrington	Jan 6, 2020	107,752 shares, last reported balance as of Jan 2, 2020
Christi Shaw	May 16, 2019	500 shares, last reported balance as of May 3, 2019
Ellen Marram	Apr 17, 2019	56,645 shares, last reported balance as of Apr 15, 2019
Enrique Conterno	Feb 20, 2019	138,121 shares, last reported balance as of Feb 15, 2019
Susan Mahony	Feb 1, 2019	59,024 shares, last reported balance as of Apr 16, 2018
Jeffrey Simmons	Feb 1, 2019	136,539 shares, last reported balance as of May 3, 2018
Jan Lundberg	Feb 13, 2018	199,212 shares, last reported balance as of Feb 9, 2018
Derica Rice	Jan 30, 2018	405,432 shares, last reported balance as of Nov 6, 2017
Maria Crowe	Jan 30, 2018	112,269 shares, last reported balance as of Oct 27, 2017
John Lechleiter	Dec 13, 2017	1,007,981 shares, last reported balance as of May 25, 2017
Franklyn Prendergast	Nov 22, 2017	68,574 shares, last reported balance as of Nov 20, 2017
David Hoover	Nov 22, 2017	37,784 shares, last reported balance as of Nov 20, 2017
Barton Peterson	Feb 3, 2017	109,872 shares, last reported balance as of Feb 1, 2017
Fionnuala Walsh	Feb 3, 2017	109,501 shares, last reported balance as of Feb 1, 2017
Karen Horn	Dec 2, 2015	73,166 shares, last reported balance as of Nov 30, 2015
Douglas Oberhelman	Dec 2, 2014	22,675 shares, last reported balance as of Nov 28, 2014
Jacques Tapiero	Jan 30, 2014	76,418 shares, last reported balance as of Jan 28, 2014
Alfred Gilman	Dec 3, 2013	48,287 shares, last reported balance as of Nov 29, 2013
Winfried Bischoff	Dec 3, 2013	42,444 shares, last reported balance as of Nov 29, 2013
Robert Armitage	Feb 4, 2013	138,147 shares, last reported balance as of Nov 19, 2012
Anne Nobles	Feb 4, 2013	30,074 shares, last reported balance as of Dec 12, 2012
Arnold Hanish	Oct 30, 2012	32,832 shares, last reported balance as of Aug 29, 2012
Bryce Carmine	Feb 16, 2012	109,516 shares, last reported balance as of Feb 1, 2012
Frank Deane	Feb 2, 2012	36,514 shares, last reported balance as of Feb 1, 2012
Martin Feldstein	Dec 1, 2011	30,733 shares, last reported balance as of Nov 30, 2011
Steven Paul	Feb 3, 2010	78,526 shares, last reported balance as of Feb 1, 2010
Gino Santini	Feb 3, 2010	123,501 shares, last reported balance as of Dec 7, 2009
Anthony Murphy	Feb 12, 2009	54,892 shares, last reported balance as of Feb 2, 2009
Deirdre Connelly	Jan 29, 2009	55,829 shares, last reported balance as of Feb 1, 2008
Alex Azar II	Jan 29, 2009	5,014 shares, last reported balance as of Jul 2, 2007
Sidney Taurel	Jan 9, 2009	1,281,097 shares, last reported balance as of Dec 31, 2008
Michael Cook	Dec 2, 2008	17,337 shares, last reported balance as of Nov 28, 2008
George Fisher	May 2, 2008	28,942 shares, last reported balance as of Apr 30, 2008
Lorenzo Tallarigo	Apr 2, 2008	66,611 shares, last reported balance as of Mar 31, 2008
Scott Canute	Feb 12, 2007	49,401 shares, last reported balance as of Feb 1, 2007
Charles Golden	May 2, 2006	109,309 shares, last reported balance as of Apr 28, 2006
Pedro Granadillo	Feb 14, 2005	204,614 shares, last reported balance as of Sep 23, 2004
John Rose	Jan 3, 2005	1,689 shares, last reported balance as of Dec 31, 2004
Steven Beering	Dec 2, 2004	27,760 shares, last reported balance as of Nov 30, 2004
Gerhard Mayr	Feb 19, 2004	No balance on record
August Watanabe	Feb 17, 2004	502,583 shares, last reported balance as of Jun 30, 2003
John Johnson		No balance on record

Eli Lilly insiders sold $19.8M in the past 12 months. How much of their stake is that?

What stands out

Who sold, and how much of their stake

Selling by month

Outside holders, reported separately

Common questions

Is the Eli Lilly CEO selling stock?

Why are Eli Lilly insiders selling?

Are any Eli Lilly insiders buying?

How much of their stake did Eli Lilly insiders sell?

The evidence

Taxes

Sales by month